On Dec. 7, the New York Times ran an inspiring, dangerous story about Celine Ryan, a 50-year-old whose advanced colon cancer was successfully treated with experimental immunotherapy. Inspiring, because researchers repeatedly rejected Ryan’s requests to participate in a clinical trial, but her heroic refusal to accept their verdict led to her eventual admission—and remission. Dangerous, because although the article emphasizes that success in one patient proves very little, Ryan’s story served as powerful anecdotal reinforcement of a widespread and mistaken view that groundbreaking cures are stuck in trial stages, and that patients need to take it upon themselves to fight bureaucratic gatekeepers for access. This type of narrative undermines the necessity of the Food and Drug Administration, whose scientific standards are crucial to keeping medical costs down, preventing health crises, and ensuring objective evaluations of new drugs....
http://www.slate.com/articles/health_and_science/medical_examiner/2016/12/the_21st_century_cares_act_could_be_dangerous_for_everyone.html
Showing posts with label Cures Act. Show all posts
Showing posts with label Cures Act. Show all posts
Sunday, December 18, 2016
Friday, December 16, 2016
NPR: Mental Health Care Gets A Boost From 21st Century Cures Act
Early intervention for treating psychosis and grants to train more psychologists and psychiatrists are just some of the ways the legislation would change mental health services....
http://www.npr.org/sections/health-shots/2016/12/07/504725936/mental-health-care-gets-a-boost-from-21st-century-cures-act
http://www.npr.org/sections/health-shots/2016/12/07/504725936/mental-health-care-gets-a-boost-from-21st-century-cures-act
Monday, December 5, 2016
STAT: Republicans reach deal to pass Cures Act by end of year, but Democrats pushing for changes
House and Senate leaders announced late Friday night that they had finally hammered out a deal on landmark legislation designed to speed federal approval of new drugs and devices and boost funding of medical research. But what Republican lawmakers call the "final" version of the 21st Century Cures Act is actually still in negotiation with Senate Democrats, a Senate health committee senior aide told STAT on Sunday. ...
https://www.statnews.com/2016/11/27/cures-act-deal/?s_campaign=stat%3Arss
https://www.statnews.com/2016/11/27/cures-act-deal/?s_campaign=stat%3Arss
Subscribe to:
Posts (Atom)
